Figure 3.
In the absence of Myo1g, activated B lymphocytes have altered motility in a confined 3D microchannel. (a) A general model of the microfluidic chamber. This device has 96 channels with gap widths of 5, 10, and 15 μm. Each channel is 150 μm long. Briefly, LPS + IL-4 activated WT or Myo1g−/− B lymphocytes are placed by gravity inside the chamber. Then, CXCL13 is applied on the opposite side. After that, migration is recorded by time-lapse microscopy. (b) Time of contact (s) of activated WT or Myo1g−/− B lymphocytes with the 10 μm microchannel wall. (c) speed (μm/s) of activated B lymphocytes moving through a 10 μm microchannel calculated while the cells were moving within the microchannel. (d) Representative still images showing displacement of the cells over time; (red arrows). Data are presented as mean ± s.d. ****P < 0.0001.
